Quick Answer
COGNITION THERAPEUTICS INC reported Operating Income of -$47.80 million for fiscal year 2025.
COGNITION THERAPEUTICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$47.80M | +11.4% |
| 2024 | -$53.97M | -6.4% |
| 2023 | -$50.72M | -16.5% |
| 2022 | -$43.55M | -52.3% |
| 2021 | -$28.60M | -64.3% |
| 2020 | -$17.41M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.38M | +55.9% | +54.4% |
| June 30, 2025 | -$13.98M | +4.8% | -1.5% |
| March 31, 2025 | -$13.78M | +2.3% | +4.8% |
| September 30, 2024 | -$14.46M | +1.9% | +1.5% |
| June 30, 2024 | -$14.68M | -24.2% | -4.1% |
| March 31, 2024 | -$14.10M | -57.2% | +4.4% |
| September 30, 2023 | -$14.74M | -16.8% | -24.8% |
| June 30, 2023 | -$11.82M | +3.2% | -31.7% |
- COGNITION THERAPEUTICS INC showed an increase of +11.4% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, COGNITION THERAPEUTICS INC’s operating income has declined by 174.6% (from -$17.41 million to -$47.80 million).
- The most recent figure is from COGNITION THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: